More about

Sacubitril

News
August 15, 2024
4 min read
Save

Medicare announces price cuts for 10 drugs in first round of drug price negotiations

Medicare announces price cuts for 10 drugs in first round of drug price negotiations

The Centers for Medicare & Medicaid Services announced lower Medicare Part D prices for 10 drugs that will take effect in 2026, according to a press release.

News
October 07, 2020
2 min read
Save

Sacubitril/valsartan fails to show significant post-MI remodeling benefits vs. valsartan

Sacubitril/valsartan fails to show significant post-MI remodeling benefits vs. valsartan

Sacubitril/valsartan failed to demonstrate significant reverse remodeling effect compared with valsartan among patients with asymptomatic left ventricular systolic dysfunction following MI, a speaker reported.

News
August 30, 2020
4 min read
Save

Sacubitril/valsartan for HFpEF reduces NT-proBNP, but no effect on functional outcomes

Sacubitril/valsartan for HFpEF reduces NT-proBNP, but no effect on functional outcomes

The PARALLAX trial of sacubitril/valsartan for HF with preserved ejection fraction met one of its two co-primary endpoints, showing a reduction in NT-proBNP, but no additional benefit on 6-minute walk distance and functional class.

News
August 19, 2020
2 min read
Save

Sacubitril/valsartan improves renal outcomes in HFpEF, chronic kidney disease

Sacubitril/valsartan improves renal outcomes in HFpEF, chronic kidney disease

Sacubitril/valsartan was superior to valsartan alone for reduction of renal events in patients with HF and preserved ejection fraction and chronic kidney disease, researchers reported.